Whalegun
Home

David Malcom Rodman, Chief Medical Officer: Mineralys Therapeutics MLYS Sell · Filed 01/13

Trade details

Type
Insider sale
Amount
$205,167.36
Shares · price
6,348 sh · $32.32 a share
Held after
61,804 sh
Stock
Mineralys Therapeutics MLYS
Person
David Malcom RodmanChief Medical Officer
Trade date
26/01/12
Filed
26/01/13
Days to filing
1 days

Sold 9.3% of holdings

Share of holding sold
9.3%

Mineralys Therapeutics trades, last 26 weeks

What else happened in Mineralys Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/13~02/11

David Malcom Rodman's recent trades

  • David Malcom Rodman

    Planned sale10b5-1 planMineralys Therapeutics

    $11.7K

    Filed 09/17

  • David Malcom Rodman

    Planned sale10b5-1 planMineralys Therapeutics

    $216.9K

    Filed 09/14

  • David Malcom Rodman

    Planned sale10b5-1 planMineralys Therapeutics

    $67K

    Filed 09/09

  • David Malcom Rodman

    Planned sale10b5-1 planMineralys Therapeutics

    $10.6K

    Filed 08/17

  • David Malcom Rodman

    Planned sale10b5-1 planMineralys Therapeutics

    $372.2K

    Filed 08/13